0.20572
0.01372 (7.15%)
0.01372 (7.15%)
Upgrade to Real-Time
Market Open
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Revive Therapeutics Ltd (PK) | RVVTF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.01372 | 7.15% | 0.20572 | 12:21:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2134 | 0.1918 | 0.2134 | 0.192 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.2052 | 0.206 | 0.0008 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 520 | 2,069,678 | $ 0.208272 | $ 431,056 | 2,086,639 | 0.0173 - 0.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:21:08 | 500 | $ 0.20572 | USD |
Revive Therapeutics (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 45.32M | 217.29M | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 2.89M | $ - | 0.00% | - | - |
Revive Therapeutics (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RVVTF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.167 | 0.2208 | 0.15 | 0.1781703 | 3,636,993 | 0.03872 | 23.19% |
| 1 Month | 0.16 | 0.2208 | 0.1261 | 0.1661039 | 2,239,002 | 0.04572 | 28.58% |
| 3 Months | 0.205 | 0.23825 | 0.1261 | 0.1840792 | 2,038,885 | 0.00072 | 0.35% |
| 6 Months | 0.274 | 0.50 | 0.12 | 0.2202554 | 3,350,865 | -0.06828 | -24.92% |
| 1 Year | 0.02 | 0.50 | 0.0173 | 0.2176254 | 2,034,291 | 0.18572 | 928.6% |
| 3 Years | 0.2034 | 0.50 | 0.0173 | 0.2167783 | 775,516 | 0.00232 | 1.14% |
| 5 Years | 0.5248 | 0.55 | 0.0173 | 0.2163834 | 600,191 | -0.31908 | -60.8% |
Revive Therapeutics (PK) Description
| Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive's cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit www.ReviveThera.com. |
